Share
Journal Information
Issue
Vol. 37. Issue 1.Pages 1-70 (January - February 2015)
Editorial
Many thanks to our eternal Editor of the Revista Brasileira de Hematologia e Hemoterapia, Professor Milton Artur Ruiz
Cármino Antonio de Souza
Rev Bras Hematol Hemoter. 2015;37:1-2
Open access
Scientific comment
Myeloid leukemia: are we getting better?
Nelson Hamerschlak
Rev Bras Hematol Hemoter. 2015;37:3-4
Open access
The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão
Marcos Borato Viana
Rev Bras Hematol Hemoter. 2015;37:5-6
Open access
Original
Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil
Fernando Callera, Alexandra Fernandes Callera, Evandro Secchi Rosa
Rev Bras Hematol Hemoter. 2015;37:7-11
Open access
Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhão, Brazil
Ana Ranoy Gomes Lima, Valdinar Sousa Ribeiro, Dario Itapary Nicolau
Rev Bras Hematol Hemoter. 2015;37:12-6
Open access
Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients
Maria de Lourdes Lopes Ferrari Chauffaille, Ana Carolina de Almeida Bandeira, Aline Schiavoni Guarnieri da Silva
Rev Bras Hematol Hemoter. 2015;37:17-20
Open access
Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná
Sergio Lunardon Padilha, Emannuely Juliani dos Santos Souza, Marcela Coriolano Cruz Matos, Natália Ramos Domino
Rev Bras Hematol Hemoter. 2015;37:21-7
Open access
Results of high-risk neutropenia therapy of hematology–oncology patients in a university hospital in Uruguay
Matilde Boada Burutaran, Regina Guadagna, Sofia Grille, Mariana Stevenazzi, Cecilia Guillermo, Lilian Diaz
Rev Bras Hematol Hemoter. 2015;37:28-33
Open access
Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma
Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger, Zahit Bolaman
Rev Bras Hematol Hemoter. 2015;37:34-7
Open access
Association between maternal and fetal factors and quality of cord blood as a source of stem cells
Rodrigo Dias Nunes, Flávia Maria Zandavalli
Rev Bras Hematol Hemoter. 2015;37:38-42
Open access
Prevalence of anemia in a sample of elderly southeastern Brazilians
Fernando Callera, Alexandra Fernandes Callera, Adriano Moraes da Silva, Evandro Secchi Rosa
Rev Bras Hematol Hemoter. 2015;37:43-7
Open access
Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes
Thiago Rodrigo de Noronha, Sandra Serson Rohr, Maria de Lourdes Lopes Ferrari Chauffaille
Rev Bras Hematol Hemoter. 2015;37:48-54
Open access
Case report
A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment
Mariana Beatriz Asinari, Maximiliano Zeballos, Sturich Alicia, Brenda Nidia Ricchi, Ana Lisa Basquiera
Rev Bras Hematol Hemoter. 2015;37:55-7
Open access
Special article
Teaching transfusion medicine: current situation and proposals for proper medical training
Gustavo de Freitas Flausino, Flávio Ferreira Nunes, Júnia Guimarães Mourão Cioffi, Anna Bárbara de Freitas Carneiro Proietti
Rev Bras Hematol Hemoter. 2015;37:58-62
Open access
Motivating medical students to learn basic science concepts using chronic myeloid leukemia as an integration theme
Sara Teresinha Olalla Saad, Hernandes Faustino Carvalho
Rev Bras Hematol Hemoter. 2015;37:63-6
Open access
Letter
Why and how validate criteria by manual smear review to improve laboratory productivity?
Helena Zerlotti Wolf Grotto
Rev Bras Hematol Hemoter. 2015;37:67-8
Open access
To follow or not to follow the recommendations regarding microscopic analysis of the Clinical and Laboratory Standards Institute H20-A2 to validate the criteria for blood smear review?
Samuel Ricardo Comar, Mariester Malvezzi, Ricardo Pasquini
Rev Bras Hematol Hemoter. 2015;37:69-70
Open access
Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.